Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 25, Issue 3, Pages 307-316Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2014.04.006
Keywords
Cancer; Virus; ACKR3/CXCR7; CXCL12/SDF-1; CXCR4
Categories
Funding
- Agence Nationale de la Recherche [2010-JCJC-110401]
- ANR [ANR-10-LABX-33, ANR-11-IDEX-0003-01]
- DIM Biotherapies
- French Ministry
- Assistance Publique - Hopitaux de Paris
Ask authors/readers for more resources
Recent studies have highlighted the importance of understanding the molecular determinants of CXCL12-mediated effects in cancers. Once previously thought to interact exclusively with OCCR4, CXCL12 also binds with high affinity to OCCR7 (recently renamed ACKR3), which belongs to an atypical chemokine receptor family whose members fail to activate God proteins but interact with beta-arrestins. In addition to its capacity to control CXCL12 bioavailability, ACKR3 can either enhance or dampen CXCR4-mediated signaling and activity. In light of the most recent findings, we have examined the role of ACKR3 in cancer, including a subset of virus-related cancers. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available